PMID- 35982828
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220820
IS  - 2325-9671 (Print)
IS  - 2325-9671 (Electronic)
IS  - 2325-9671 (Linking)
VI  - 10
IP  - 8
DP  - 2022 Aug
TI  - Is the VISA-A Still Seaworthy, or Is It in Need of Maintenance?
PG  - 23259671221108950
LID - 10.1177/23259671221108950 [doi]
LID - 23259671221108950
AB  - BACKGROUND: The Victorian Institute of Sport Assessment-Achilles (VISA-A) 
      questionnaire is validated and widely used in Achilles tendinopathy. How well it 
      can evaluate treatment outcomes is not well understood. PURPOSE: To evaluate the 
      responsiveness of the VISA-A in midportion Achilles tendinopathy and compare it 
      with other patient-reported outcome measures. STUDY DESIGN: Cohort study 
      (diagnosis); Level of evidence, 2. METHODS: Enrolled were 97 participants with 
      clinically diagnosed Achilles tendinopathy (median age, 50 years [interquartile 
      range, 18 years]; symptom duration, 10 months [interquartile range, 28.7 months). 
      The participants underwent a baseline evaluation and completed between 1 and 6 
      follow-up evaluations at 8, 16, 24, 32, 40, and/or 48 weeks. Participants 
      completed the VISA-A, the Patient Reported Outcomes Measurement Information 
      System short form Version 2.0 (PROMIS) Physical Function and Pain Interference 
      subscales, and the Tampa Scale for Kinesiophobia (TSK). Three thresholds were 
      evaluated with a receiver operating characteristic analysis (minimal clinically 
      important difference [MCID], substantial benefit [SB], and complete recovery 
      [CR]) using an 11-point global rating of change scale as an anchor. Thresholds 
      were evaluated on raw scores as well as changes from baseline. RESULTS: The 
      VISA-A was able to detect all 3 thresholds for changes over time, with raw scores 
      >70.5, >77.5, and >89.5 representing the MCID, SB, and CR, respectively; 
      thresholds for changes from baseline on the VISA-A were increases of 23.5, 19.5, 
      and 37.5 points from baseline, respectively. The PROMIS subscale raw scores had 
      identical thresholds for SB and CR (52.45 for Physical Function and 45.6 for Pain 
      Interference). A score <34.5 on the TSK was the threshold for SB. CONCLUSION: The 
      VISA-A was the most responsive outcome measure evaluated. Raw scores had 
      increasingly higher thresholds for the MCID, SB, and CR, which were therefore 
      logically consistent.
CI  - (c) The Author(s) 2022.
FAU - Sigurethsson, Haraldur B
AU  - Sigurethsson HB
AD  - School of Health Sciences, University of Iceland, Reykjavik, Iceland.
FAU - Gravare Silbernagel, Karin
AU  - Gravare Silbernagel K
AD  - Department of Physical Therapy, University of Delaware, Newark, Delaware, USA.
LA  - eng
PT  - Journal Article
DEP - 20220812
PL  - United States
TA  - Orthop J Sports Med
JT  - Orthopaedic journal of sports medicine
JID - 101620522
PMC - PMC9380230
OTO - NOTNLM
OT  - Achilles tendinopathy
OT  - clinimetrics
OT  - midportion
OT  - minimal clinically important difference
OT  - patient-reported outcome measures
OT  - responsiveness
COIS- One or more of the authors has declared the following potential conflict of 
      interest or source of funding: Research reported in this publication was 
      supported by the National Institute of Arthritis and Musculoskeletal and Skin 
      Diseases of the National Institutes of Health (award No. R01AR072034). AOSSM 
      checks author disclosures against the Open Payments Database (OPD). AOSSM has not 
      conducted an independent investigation on the OPD and disclaims any liability or 
      responsibility relating thereto.
EDAT- 2022/08/20 06:00
MHDA- 2022/08/20 06:01
PMCR- 2022/08/12
CRDT- 2022/08/19 02:07
PHST- 2022/03/10 00:00 [received]
PHST- 2022/04/08 00:00 [accepted]
PHST- 2022/08/19 02:07 [entrez]
PHST- 2022/08/20 06:00 [pubmed]
PHST- 2022/08/20 06:01 [medline]
PHST- 2022/08/12 00:00 [pmc-release]
AID - 10.1177_23259671221108950 [pii]
AID - 10.1177/23259671221108950 [doi]
PST - epublish
SO  - Orthop J Sports Med. 2022 Aug 12;10(8):23259671221108950. doi: 
      10.1177/23259671221108950. eCollection 2022 Aug.